HPLC vs mass spectrometry: what each one tells you
HPLC measures how much of the sample is the compound. Mass spectrometry measures whether the compound is the one you asked for. Run only one of them and you leave a specific, predictable gap.
They answer different questions
HPLC, high performance liquid chromatography, separates a mixture. The sample is pushed through a column packed with a water-repelling material, usually C18 silica, while the solvent shifts from mostly water toward mostly acetonitrile. Components leave the column in order of how strongly they stick. A detector watches the outflow, and the result is a trace with one peak for each thing that came off separately.
Mass spectrometry does not separate anything. It ionizes the sample and measures mass-to-charge ratio. What comes back is a mass, which can be compared against the mass the sequence predicts.
So HPLC gives you a share with no identity attached, and mass spectrometry gives you an identity with no share attached. Neither is the whole answer. A good certificate reports both, or reports identity another way, such as retention time against a reference standard.
What each one catches
HPLC catches quantity problems
Truncated sequences, deletion products where a coupling step failed, residual protecting groups, dimers, and anything else that came off the column at a different time. It quantifies all of them relative to the main peak.
MS catches identity problems
The wrong compound entirely, an oxidized residue running 16 mass units heavy, a deamidation running one unit heavy, an incomplete deprotection carrying extra mass. Anything that changes the total, it sees.
HPLC misses identity
A single sharp peak at 99 percent tells you one thing came off the column. It does not tell you what that thing was. Sell the wrong peptide at high purity and the chromatogram looks great.
MS misses proportion
Ionisation efficiency differs between molecules, so peak height in a mass spectrum is not a reliable measure of how much of each is present. A correct mass is compatible with a fairly dirty sample.
How the two runs are usually configured
- Column
- C18, 4.6 x 250 mm, 5 micron particle, 300 angstrom pore
- Mobile phase A
- Water with 0.1 percent trifluoroacetic acid
- Mobile phase B
- Acetonitrile with 0.1 percent trifluoroacetic acid
- Gradient
- Commonly 5 to 65 percent B over 20 to 30 minutes
- Detection
- Ultraviolet at 214 nm, the amide bond absorbance
- MS ionization
- Electrospray for solution phase, MALDI for solid phase
- MS reporting
- Theoretical average or monoisotopic mass against observed
Typical reversed-phase conditions for a synthetic peptide. Specific gradients vary by sequence.
Where both of them stop
Mass is a sum, and sums lose information. Reorder the residues in a sequence and the mass is identical. Swap leucine for isoleucine, which are structural isomers, and the mass is identical to the fourth decimal place. Neither instrument, run this way, separates those cases.
Closing that gap takes peptide mapping, where the material is cut with a protease and the fragments are run by liquid chromatography against mass spectrometry, or direct sequencing. Both are standard techniques. Both cost several times what a purity run costs, which is why almost no supplier in this market runs them, and why a claim of sequence verification deserves a close read.
Questions
Common questions
Is a peptide that passes HPLC and MS guaranteed to be correct?
No. The pair confirms that the material is largely one compound and that the compound has the expected total mass. A sequence with two residues transposed passes both. Confirming order requires peptide mapping or sequencing, which is a separate and more expensive analysis.
What does a shoulder on the main HPLC peak mean?
Usually a closely related impurity that the gradient did not fully resolve, commonly a deamidated form or a diastereomer. Integration software will often roll a shoulder into the main peak, which inflates the reported purity. It is one of the reasons the trace is worth more than the number.
Why does trifluoroacetic acid appear in the mobile phase?
It acts as an ion pairing agent, sharpening peaks and improving resolution on reversed phase. It also ends up as the counterion on the finished peptide, which is why TFA content is a separate line on a certificate and why it eats into net peptide content.
MALDI or electrospray?
MALDI tolerates salt better, gives mostly singly charged ions and reads more directly, which suits a lyophilized powder. Electrospray couples straight to the liquid chromatography run so identity and purity come from the same injection. Either is fine. Neither being present is the problem.
Cite as: SBz Industries research library, "HPLC vs mass spectrometry: what each one tells you", https://www.sbzindustries.com/research/hplc-vs-mass-spectrometry, updated 2026-09-11.
Keep reading
Related guides
Documentation
Every compound, its certificate published
We expect the checks on this page to be run on our own paperwork. The latest certificate for every compound is on its product page.